Latest Research in Retinal Diseases and Treatments
44 research papers · 2026 median publication year
Top Research Topics in Retinal Diseases and Treatments
- Retinal Diseases and Treatments — 37 papers
- Ocular Diseases and Behçet’s Syndrome — 3 papers
- Ocular Infections and Treatments — 1 papers
- Curcumin's Biomedical Applications — 1 papers
- Glaucoma and retinal disorders — 1 papers
- Retinal and Optic Conditions — 1 papers
Highest-Cited Papers
- Factors associated with macular oedema regression and visual outcomes after dexamethasone implant therapy in uveitic macular oedema
- Early Effect of Intravitreal Faricimab on Hard Exudates in Diabetic Macular Oedema
- Adalimumab Therapy Reduces Treatment Burden in Multifocal Choroiditis/Punctate Inner Choroidopathy
- Infographic: Efficacy and safety of high-dose intravitreal aflibercept 8 mg in patients with diabetic macular oedema: week 96 results from the phase 2/3 PHOTON trial
- Effects of Intravitreal Anti-VEGF Therapy on Conjunctival Flora and Antibiotic Resistance in Age-Related Macular Degeneration
- Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice
- Evaluation of treatment interval extension and short-term stability after switching to faricimab in neovascular AMD, a mid-term observational study.
- COMPARATIVE CLINICAL OUTCOMES OF FARICIMAB VERSUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: A FOCUSED REVIEW
- Two-year real-world effectiveness of faricimab after treatment switch in neovascular age-related macular degeneration
- Real-world comparative effectiveness of faricimab versus aflibercept 2 mg in treatment-naïve exudative neovascular AMD patients treated with a treat-and-extend regimen
- Short-term effects of oral curcumin as adjunct to intravitreal bevacizumab in diabetic macular edema: a randomized clinical trial
- Twelve‑month Response and Safety of Intravitreal Dexamethasone Implant in Treatment‑Naïve and Recalcitrant Cystoid Macular Edema Secondary to Branch Retinal Vein Occlusion (TREAT-BRVO Study)
- Extended-interval outcomes with aflibercept 8 mg in diabetic macular edema: Real-world evidence from naïve and switch cohorts
- Six-month outcomes with a reduced two-injection induction (2+TAE) regimen of aflibercept 8 mg in treatment-naive neovascular age-related macular degeneration
- Noninfectious intraocular inflammation with hypopyon after intravitreal aflibercept 8 mg injection for neovascular age-related macular degeneration: a case report
- OCT as a Dynamic Biomarker in Retinal Disease Management: Evidence, Decision Strategies, and Clinical Guidance for OCT Decision-Point Use
- Consecutive Dexamethasone–Fluocinolone Acetonide Therapy in Non-Infectious Uveitic Macular Edema: Real-World Outcomes
- Clinical Outcomes After Same-Agent Double-Dose Anti-VEGF Escalation in Eyes with a Suboptimal Response to Standard-Dose Treatment for Exudative Macular Diseases: A Real-World Pre–Post Study
- Five-Year outcomes of the use of the dexamethasone implant in phakic, treatment-naïve patients with diabetic macular edema
- Real-World Outcomes of Faricimab for Polypoidal Choroidal Vasculopathy in a Multi-ethnic Cohort: A 12-Month Retrospective Study